Administrative Core
行政核心
基本信息
- 批准号:7976432
- 负责人:
- 金额:$ 14.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventAdvisory CommitteesAgingAreaBasic ScienceCollaborationsCommunicationCommunitiesComplexConsultationsDataDevelopmental DisabilitiesEnsureEvaluationFundingGoalsGrowthIndividualInformed ConsentInstitutesInstitutionLeadershipMethodsNatureNew YorkParticipantPrincipal InvestigatorProceduresProcessProductivityProgress ReportsRegulationReportingResearchResearch Ethics CommitteesResearch PersonnelResourcesRoleScheduleSpecific qualifier valueStructureTimeUnited States National Institutes of HealthUniversitiesmedical schoolsmeetingsmemberoperationprogramssuccess
项目摘要
The Administration Core will have the primary responsibility for Program management and coordination. While the individual components of our Program can function independently in many respects, success during the next five years depends to a substantial degree on effective interactions among investigators at four major research institutions. Therefore, there will be constant needs to maintain open lines of communication, and to ensure that daily operations are carried out both efficiently and effectively. Thus, the Principal Investigator(s) of each component of our Program also will devote time and effort to program
management and central coordination within the Administration Core. This will encourage our individual projects to continue to function as parts of a highly integrated whole. In addition, because our Aging Research Program has expanded to include other NIH funded projects as outlined in the introduction of this application, an aim of this Core will be to maintain collaborative relationships with these other efforts. These overall goals will be accomplished through: (a) management and coordination of program activities; (b) oversight of administrative requirements (e.g., coordination of IRB review and procedures for obtaining informed consents); (c) provision of statistical consultation to program investigators; (d) tracking of adverse events and developing necessary reports to oversight groups (e.g., IRBs at cooperating institutions, NIH), and (e) stimulation of productivity and dissemination of findings. An Advisory Committee will also be formed to review activities and progress and ensure that this program continues: (a) to meet its aims successfully, and (b) to retain its leadership role within this rapidly evolving field. The Committee will meet annually, and
members will be available as needed should needs arise for additional advice.
行政核心将主要负责项目管理和协调。虽然我们计划的各个组成部分可以在许多方面独立运作,但未来五年的成功在很大程度上取决于四个主要研究机构的研究人员之间的有效互动。因此,将需要不断保持畅通的沟通渠道,并确保有效率和有成效地开展日常业务。因此,我们计划每个组成部分的主要研究者也将投入时间和精力来计划
在行政核心内进行管理和中央协调。这将鼓励我们的个别项目继续作为一个高度一体化的整体的一部分发挥作用。此外,由于我们的老龄化研究计划已经扩展到包括其他NIH资助的项目,如本申请的介绍中所述,本核心的目的是保持与这些其他工作的合作关系。这些总体目标将通过以下方式实现:(a)管理和协调计划活动;(B)监督行政要求(例如,协调IRB审查和获得知情同意的程序);(c)向项目研究者提供统计咨询;(d)跟踪不良事件并向监督小组编写必要的报告(例如,合作机构的审查委员会,国家卫生研究院),以及(e)促进生产力和传播研究结果。还将成立一个咨询委员会,审查活动和进展情况,并确保该方案继续:(a)成功实现其目标,(B)在这一迅速发展的领域保持其领导作用。委员会每年举行一次会议,
如有需要,委员会成员可随时提供额外意见。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAYNE P. SILVERMAN其他文献
WAYNE P. SILVERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAYNE P. SILVERMAN', 18)}}的其他基金
Intellectual and Developmental Disabilities Research Centers 2013
智力和发育障碍研究中心 2013
- 批准号:
8846261 - 财政年份:2014
- 资助金额:
$ 14.77万 - 项目类别:
Intellectual and Developmental Disabilities Research Centers 2013
智力和发育障碍研究中心 2013
- 批准号:
8931780 - 财政年份:2014
- 资助金额:
$ 14.77万 - 项目类别:
Changes in Functioning among Mentally Retarded Adults
智障成人的功能变化
- 批准号:
7896990 - 财政年份:2009
- 资助金额:
$ 14.77万 - 项目类别:
CHANGES IN FUNCTIONING AMONG MENTALLY RETARDED ADULTS
智障成人的功能变化
- 批准号:
2838849 - 财政年份:1998
- 资助金额:
$ 14.77万 - 项目类别:
Changes in Functioning among Mentally Retarded Adults
智障成人的功能变化
- 批准号:
6944372 - 财政年份:1998
- 资助金额:
$ 14.77万 - 项目类别:
Aging and Dementia in Adults with Down Syndrome
唐氏综合症成人的衰老和痴呆
- 批准号:
8678955 - 财政年份:1998
- 资助金额:
$ 14.77万 - 项目类别:
CHANGES IN FUNCTIONING AMONG MENTALLY RETARDED ADULTS
智障成人的功能变化
- 批准号:
6476804 - 财政年份:1998
- 资助金额:
$ 14.77万 - 项目类别:
Changes in Functioning among Mentally Retarded Adults
智障成人的功能变化
- 批准号:
6805764 - 财政年份:1998
- 资助金额:
$ 14.77万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 14.77万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 14.77万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 14.77万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 14.77万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 14.77万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 14.77万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 14.77万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 14.77万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 14.77万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 14.77万 - 项目类别:














{{item.name}}会员




